86 related articles for article (PubMed ID: 8918488)
1. Complications of venous access ports in 132 patients with disseminated testicular cancer treated with polychemotherapy.
Lemmers NW; Gels ME; Sleijfer DT; Plukker JT; van der Graaf WT; de Langen ZJ; Droste JH; Koops HS; Hoekstra HJ
J Clin Oncol; 1996 Nov; 14(11):2916-22. PubMed ID: 8918488
[TBL] [Abstract][Full Text] [Related]
2. Follow-up of radiologically totally implanted central venous access ports of the upper arm: long-term complications in 127,750 catheter-days.
Busch JD; Herrmann J; Heller F; Derlin T; Koops A; Adam G; Habermann CR
AJR Am J Roentgenol; 2012 Aug; 199(2):447-52. PubMed ID: 22826411
[TBL] [Abstract][Full Text] [Related]
3. Use of vascular access ports in femoral veins of dogs and cats with cancer.
Cahalane AK; Rassnick KM; Flanders JA
J Am Vet Med Assoc; 2007 Nov; 231(9):1354-60. PubMed ID: 17975994
[TBL] [Abstract][Full Text] [Related]
4. Subcutaneous venous port implantation in adult patients: a single center experience.
Cil BE; Canyiğit M; Peynircioğlu B; Hazirolan T; Carkaci S; Cekirge S; Balkanci F
Diagn Interv Radiol; 2006 Jun; 12(2):93-8. PubMed ID: 16752357
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin-Based Chemotherapy for Testicular Germ Cell Tumors: Complication Rates of Peripheral versus Central Venous Administration.
Worst T; Sautter L; John A; Weiss C; Häcker A; Heinzelbecker J
Urol Int; 2016; 96(2):177-82. PubMed ID: 26681435
[TBL] [Abstract][Full Text] [Related]
6. Complications associated with the use of vascular access ports in dogs receiving external beam radiation therapy.
Mayer MN; Grier CK; Yoshikawa H; Ringwood PB
J Am Vet Med Assoc; 2008 Jul; 233(1):96-103. PubMed ID: 18593316
[TBL] [Abstract][Full Text] [Related]
7. [Complications of central venous access devices: outcome analysis of 2359 implantations].
Stein M; Wagner RH
Dtsch Med Wochenschr; 2005 May; 130(18):1129-32. PubMed ID: 15856394
[TBL] [Abstract][Full Text] [Related]
8. Long-term Outcome of Peripherally Implanted Venous Access Ports in the Forearm in Female Cancer Patients.
Klösges L; Meyer C; Boschewitz J; Andersson M; Rudlowski C; Schild HH; Wilhelm K
Cardiovasc Intervent Radiol; 2015 Jun; 38(3):657-64. PubMed ID: 25209595
[TBL] [Abstract][Full Text] [Related]
9. Long-term experience with a totally implanted catheter system in gynecologic oncologic patients.
Koonings PP; Given FT
J Am Coll Surg; 1994 Feb; 178(2):164-6. PubMed ID: 8173727
[TBL] [Abstract][Full Text] [Related]
10. [Long-term outcomes and complications of upper arm central venous access ports].
Ide Y; Mikami K; Murata K
Gan To Kagaku Ryoho; 2013 Mar; 40(3):331-5. PubMed ID: 23507594
[TBL] [Abstract][Full Text] [Related]
11. Experience with implanted subcutaneous ports for intraperitoneal chemotherapy in ovarian cancer.
Malmström H; Carstensen J; Simonsen E
Gynecol Oncol; 1994 Jul; 54(1):27-34. PubMed ID: 8020835
[TBL] [Abstract][Full Text] [Related]
12. Subcutaneous venous port implantation in patients with bilateral breast surgery.
Peynircioglu B; Arslan EB; Cil BE; Geyik S; Hazirolan T; Konan A; Balkanci F
Cardiovasc Intervent Radiol; 2007; 30(3):405-9. PubMed ID: 17278032
[TBL] [Abstract][Full Text] [Related]
13. [Implantable catheter systems. Experiences with 1000 patients with central venous ports].
Kock HJ; Krause U; Pietsch M; Rasfeld S; Walz MK
Dtsch Med Wochenschr; 1996 Jan; 121(3):47-51. PubMed ID: 8565809
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of venous access port-related infections.
Douard MC; Arlet G; Longuet P; Troje C; Rouveau M; Ponscarme D; Eurin B
Clin Infect Dis; 1999 Nov; 29(5):1197-202. PubMed ID: 10524963
[TBL] [Abstract][Full Text] [Related]
15. Complications and management of an implanted intraperitoneal access port system for intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis.
Emoto S; Ishigami H; Hidemura A; Yamaguchi H; Yamashita H; Kitayama J; Watanabe T
Jpn J Clin Oncol; 2012 Nov; 42(11):1013-9. PubMed ID: 22872745
[TBL] [Abstract][Full Text] [Related]
16. [Infectious and non-infectious complications of tunneled central catheters in hematologic patients].
Albo López C; López Rodríguez D; Constenla Camba MI; Jimenéz Blanco A; Araujo LF; García-Medina J
Sangre (Barc); 1999 Jun; 44(3):176-81. PubMed ID: 10481577
[TBL] [Abstract][Full Text] [Related]
17. The late complications of totally implantable central venous access ports: the results from an Italian multicenter prospective observation study.
Dal Molin A; Rasero L; Guerretta L; Perfetti E; Clerico M
Eur J Oncol Nurs; 2011 Dec; 15(5):377-81. PubMed ID: 21167777
[TBL] [Abstract][Full Text] [Related]
18. Complications related to indwelling caval catheters on a gynecologic oncology service.
Silver DF; Hempling RE; Recio FO; Piver MS; Eltabbakh GH
Gynecol Oncol; 1998 Sep; 70(3):329-33. PubMed ID: 9790783
[TBL] [Abstract][Full Text] [Related]
19. [Complications after insertion of a totally implantable venous access port in patients treated with chemotherapy for head and neck squamous cell carcinoma].
Hoareau-Gruchet F; Rtail R; Sulaj H; Khirnetkina A; Reyt E; Righini CA
Ann Otolaryngol Chir Cervicofac; 2009 Apr; 126(2):43-52. PubMed ID: 19324328
[TBL] [Abstract][Full Text] [Related]
20. [Experiences with ultrasound-guided port implantations via the lateral subclavian vein: a retrospective analysis of 1532 patients].
Chang DH; Boecker J; Hellmich M; Krug KB
Rofo; 2012 Aug; 184(8):726-33. PubMed ID: 22618474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
